Walleye Capital’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,071
Closed -$1.36M 5036
2026
Q1
$1.36M Buy
+19,071
New +$1.3M 0.01% 1800
2024
Q1
Sell
-7,842
Closed -$370K 5728
2023
Q4
$370K Buy
+7,842
New +$326K ﹤0.01% 3182
2020
Q2
Sell
-9,152
Closed -$322K 847
2020
Q1
$322K Buy
+9,152
New +$535K 0.07% 323

Other funds holding NGVT

Walleye Capital's NGVT Position: Q2 2026 in Review

Walleye Capital sold out of Ingevity (NGVT) in Q2 2026, closing a stake of 19,071 shares — an estimated $1.36M sold.

Walleye Capital first reported a position in NGVT in Q1 2020 and held it in 3 quarters. The position peaked at $1.36M in Q1 2026. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Walleye Capital reported no remaining Ingevity position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 19,071 Ingevity shares in Q2 2026, an estimated $1.36M.
  • Walleye Capital first reported a position in Ingevity in Q1 2020 and held it in 3 quarters.
  • Walleye Capital's Ingevity position peaked at $1.36M in Q1 2026.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.